Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 ends rough week in tepid fashion

Fri, 07th Jul 2023 16:55

(Alliance News) - Stock prices in Europe diverged on Friday, with the FTSE 100 underperforming, as a weaker-than-expected US jobs report did little for equities amid the expectation that the Federal is not done with hiking.

It was a better day for the CAC 40 in Paris and DAX 40 in Frankfurt, as well as the FTSE 250 in London. A stronger pound held back the FTSE 100.

The FTSE 100 index ended 23.56 points lower, or 0.3%, at 7,256.94. The FTSE 250 closed up 87.51 points, or 0.5%, at 18,003.97, while the AIM All-Share ended up 0.85 of a point, 0.1%, at 741.71.

For the week, the FTSE 100 lost 3.7%, the FTSE 250 shed 2.2% and the AIM All-Share fell 1.6%.

The Cboe UK 100 closed down 0.3% at 723.16, the Cboe UK 250 ended down 0.1% at 15,762.63, and the Cboe Small Companies fell 0.4% at 13,498.22.

In European equities on Friday, the CAC 40 in Paris ended up 0.4%, while the DAX 40 in Frankfurt added 0.5%.

"Despite modest gains for the likes of the FTSE 250, DAX and CAC 40, the FTSE 100 has struggled close to its March lows with health care and utilities acting as a ball and chain on the day, and as for the performance on the week it's been the worst week since the sharp falls we saw in March," CMC Markets analyst Michael Hewson commented.

Drugmaker AstraZeneca lost 2.1%, while Severn Trent and United Utilities gave back 2.2% and 1.7%, among the worst FTSE 100 performers.

A stronger pound also kept a lid on the blue-chip index, which is stacked with international earners.

Sterling was quoted at USD1.2832 late Friday afternoon, jumping from USD1.2690 at the London equities close on Thursday. The pound traded around its best level since June 19.

The euro traded at USD1.0949, higher than USD1.0858. Against the yen, the dollar was quoted at JPY142.27, down versus JPY144.23.

The dollar lost some momentum after the latest reading of the US labour market was cooler than expected.

According to the US Bureau of Labor Statistics, total non-farm payroll employment increased by 209,000 in June, decelerating from a revised rise of 306,000 in May.

June's figure came below expectations. According to FXStreet-cited consensus, 225,000 jobs were expected to be added last month.

The data came a day after numbers from payroll processor ADP showed US private sector employment grew by almost half a million jobs. Employment grew by 497,000 in June, rising from 278,000 in May.

What followed was some bond market chaos. The yield on the 10-year bond spiked as high as 4.08%. The two-year Treasury yield stretched as high as 5.12% on Thursday.

The weaker jobs report took some needle off government bond yields on Friday, however. The reading is unlikely to make the Federal Reserve change course, however, due to pay growth remaining robust.

Over the past 12 months, average hourly earnings increased 4.4% in June, unchanged from a month prior. This was slightly above expectations of a 4.2% increase, according to FXStreet-cited consensus.

"The slowing in payrolls alone might have given the Fed pause at their meeting later this month, but the overshoot in hourly earnings, and the upward revision to the May print, means that a hike now has to be our base case; it would take a zero core CPI print now to keep the Fed on hold. For the record, we think this hike will be a mistake, Pantheon Macroeconomics analyst Ian Shepherdson commented.

"A Fed willing to extrapolate the recent trends and take leading indicators - as well as the lags in policy - seriously, would not hike again. This is not that Fed. But the data will overtake the hawks by the end of the summer; we would be very surprised to see a further hike in September."

US stocks were mixed at the time of the European close. The Dow Jones Industrial Average fell 0.1%, the S&P 500 added 0.1% and the Nasdaq Composite climbed 0.3%.

In London, Coca-Cola HBC added 5.1%. After a stronger-than-expected finish to the first half of the year, the drinks bottler upgraded its earnings expectations for the full year.

The company now expects organic earnings before interest and tax growth of between 9% to 12% for 2023. Previously, Coca-Cola HBC had expected Ebit growth of up to 3% or a decline of up to 3%.

OSB Group tumbled 29% as it said it will take as much as a GBP180 million hit to first-half results, because customers are acting more quickly than expected to refinance their mortgages at favourable rates.

OSB, which stands for OneSavings Bank, said that as its mortgage customers reach the end of their initial fixed term, they are choosing to refinance earlier than expected and therefore spend less time on the higher reversion rate. This rate is linked to the Bank of England's bank base rate and has been rising over the past year as the central bank hikes UK interest rates.

"As the first half of 2023 progressed, the group observed a step change in the behaviour of Precise Mortgages owner-occupied and buy-to-let customers reaching the end of their initial fixed term," OSB explained.

OSB said it now expects customers to spend an average of five months on the higher reversion rate, which it said it is a reduction from its previous expectation without saying what that had been. As result of the reduced time spent at the higher rates, OSB said it will make a negative effective interest rate adjustment of GBP160 million to GBP180 million on an underlying basis against first-half results.

YouGov closed up 2.8%. It raised GBP51.2 million through a placing to go towards the acquisition of GfK's consumer panel business.

GfK's consumer panel business is focused on household purchase data, with panels across 16 European countries, consisting of over 100,000 households.

The London-based research and data analytics group said that the EUR315 million deal would not only extend its offering into the fast-moving consumer goods sector, but would help expand its offering to US clients.

Gold was quoted at USD1,929.07 an ounce late Friday, higher than USD1,909.01 on Thursday. Brent oil was trading at USD77.47 a barrel, higher than USD75.23.

Monday's economic calendar as Chinese inflation data overnight. Chancellor Andrew Bailey and Bank of England Governor Andrew Bailey speak at the yearly Mansion House event, meanwhile.

The local corporate calendar has quarterly numbers from self-storage firm Big Yellow Group on Monday.

This time next week, investors will be digesting the first batch of quarterly earnings from US banking stocks, with Citigroup, JPMorgan Chase and Wells Fargo reporting before the opening bell in New York.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.